News Focus
News Focus
Followers 143
Posts 24077
Boards Moderated 0
Alias Born 06/13/2011

Re: Pyrrhonian post# 88939

Monday, 08/15/2016 11:18:28 AM

Monday, August 15, 2016 11:18:28 AM

Post# of 448134
PY ..just a quick note .

Believe Lovaza sales in total are lower now then 5 yrs ago . There is reduced coverage for Omacor ( lovaza ) in Europe.
TG's jump around a lot depending on diet .
In the R-IT screening process they also screen you for how reliable a participant you will be . They emphasize the importance of the study and the safely of Vascepa and the placebo.
Most in the trial will be in their 60's , many with some college education ...so they ask, can you be a reliable, responsible participant here .
There is no down side to being in R-IT ...I would expect that over all , lipid panels could even improve in the placebo arm ...just more so in the active arm.

Re The Cardiologist who prescribed me Vascepa . I think the A Fib warning on Lovaza was a major concern for him for many of his patients . For me it was my stubbonly high LDL levels.
Kiwi
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News